These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35261120)

  • 41. Efficacy of intracervicovaginal misoprostol in second-trimester pregnancy termination: a comparison between live and dead fetuses.
    Srisomboon J; Pongpisuttinun S
    J Obstet Gynaecol Res; 1998 Feb; 24(1):1-5. PubMed ID: 9564098
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vaginal versus sublingual misoprostol for second-trimester pregnancy termination and effect on Doppler measurements.
    Karsidag AY; Buyukbayrak EE; Kars B; Dansuk R; Unal O; Turan MC
    Int J Gynaecol Obstet; 2009 Sep; 106(3):250-3. PubMed ID: 19428005
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A randomised controlled trial of 6 and 12 hourly administration of vaginal misoprostol for second trimester pregnancy termination.
    Herabutya Y; Chanrachakul B; Punyavachira P
    BJOG; 2005 Sep; 112(9):1297-301. PubMed ID: 16101611
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Randomized trial of buccal versus vaginal misoprostol for induction of second trimester abortion.
    Ellis SC; Kapp N; Vragpvoc O; Borgata L
    Contraception; 2010 May; 81(5):441-5. PubMed ID: 20399952
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Randomized controlled trial comparing efficacy between a vaginal misoprostol loading and non-loading dose regimen for second-trimester pregnancy termination.
    Pongsatha S; Tongsong T
    J Obstet Gynaecol Res; 2014 Jan; 40(1):155-60. PubMed ID: 24033985
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of vaginal versus oral misoprostol to terminate second-trimester pregnancy.
    Yazdani SH; Zeinalzadeh M; Bouzari Z; Golsorkhtabar-Amiri M
    Clin Exp Obstet Gynecol; 2012; 39(4):529-31. PubMed ID: 23444761
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vaginal Misoprostol Compared With Buccal Misoprostol for Termination of Second-Trimester Pregnancy: A Randomized Controlled Trial.
    Al RA; Yapca OE
    Obstet Gynecol; 2015 Sep; 126(3):593-598. PubMed ID: 26181087
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sublingual compared with oral and vaginal misoprostol for termination of pregnancy with second-trimester fetal demise.
    Elhassan EM; Abubaker MS; Adam I
    Int J Gynaecol Obstet; 2008 Jan; 100(1):82-3. PubMed ID: 17888920
    [No Abstract]   [Full Text] [Related]  

  • 49. Vaginal misoprostol for pre-abortion cervical priming: is there an optimal evacuation time interval?
    Singh K; Fong YF; Prasad RN; Dong F
    Br J Obstet Gynaecol; 1999 Mar; 106(3):266-9. PubMed ID: 10426647
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Randomized study on the effect of adding oxytocin to ethacridine lactate or misoprostol for second-trimester termination of pregnancy.
    Kelekci S; Erdemoglu E; Inan I
    Acta Obstet Gynecol Scand; 2006; 85(7):825-9. PubMed ID: 16817081
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors influencing the abortion interval of second trimester pregnancy termination using misoprostol.
    Ting WH; Peng FH; Lin HH; Lu HF; Hsiao SM
    Taiwan J Obstet Gynecol; 2015 Aug; 54(4):408-11. PubMed ID: 26384060
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A randomized trial of oral and vaginal misoprostol to manage delivery in cases of fetal death.
    Chittacharoen A; Herabutya Y; Punyavachira P
    Obstet Gynecol; 2003 Jan; 101(1):70-3. PubMed ID: 12517648
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative study of intravaginal misoprostol with gemeprost as an abortifacient in second trimester missed abortion.
    Eng NS; Guan AC
    Aust N Z J Obstet Gynaecol; 1997 Aug; 37(3):331-4. PubMed ID: 9325520
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcomes of Pregnancy Termination of Dead Fetus in Utero in Second Trimester by Misoprostol with Various Regimens.
    Pongsatha S; Suntornlimsiri N; Tongsong T
    Int J Environ Res Public Health; 2022 Oct; 19(19):. PubMed ID: 36231955
    [No Abstract]   [Full Text] [Related]  

  • 55. Vaginal misoprostol vs. concentrated oxytocin plus low-dose prostaglandin E2 for second trimester pregnancy termination.
    Owen J; Hauth JC
    J Matern Fetal Med; 1999; 8(2):48-50. PubMed ID: 10090490
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of vaginal and sublingual misoprostol for second trimester abortion: randomized controlled equivalence trial.
    von Hertzen H; Piaggio G; Wojdyla D; Nguyen TM; Marions L; Okoev G; Khomassuridze A; Kereszturi A; Mittal S; Nair R; Daver R; Pretnar-Darovec A; Dickson K; Nguyen DH; Nguyen HB; Hoang TD; Peregoudov A;
    Hum Reprod; 2009 Jan; 24(1):106-12. PubMed ID: 18794161
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486).
    el-Refaey H; Hinshaw K; Templeton A
    Hum Reprod; 1993 Oct; 8(10):1744-6. PubMed ID: 8300840
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy.
    Tang OS; Lau WN; Chan CC; Ho PC
    BJOG; 2004 Sep; 111(9):1001-5. PubMed ID: 15327617
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Second-trimester postabortion care for ruptured membranes, fetal demise, and incomplete abortion.
    Mark AG; Edelman A; Borgatta L
    Int J Gynaecol Obstet; 2015 May; 129(2):98-103. PubMed ID: 25660084
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of oral versus vaginal misoprostol for mid-trimester pregnancy termination.
    Mahjabeen ; Khawaja NP; Rehman R
    J Coll Physicians Surg Pak; 2009 Jun; 19(6):359-62. PubMed ID: 19486574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.